~~<i id='32B3525766'><strike id='32B3525766'><tt id='32B3525766'><pre id='32B3525766'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：Wikipedia 2025-09-28 01:34:47 - browse：89

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Listen: More tumult at BIO & coercive care for sickle cell patients

focus

hotspot

Wikipedia

explore

hotspot

ForensicmedicalexaminersworkatthescenewhereanunidentifiedmanwaskilledinApatzingan,Mexico,Sunday,July

WSS

STAT wants to know your pick for a great summer read or listen

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Biogen joins immunology wave with $1.15 billion acquisition of HI

H5N1 bird flu outbreak: Second human case reported, in Michigan

UpToDate has a racism problem: Dr. Stanley Goldfarb

Skip the lead apron during X

focus

explore

focus

What does generative AI mean for health care? We asked experts

STAT wants to know your pick for a great summer read or listen

Malaria cases in Florida and Texas: Here’s what you need to know

A letter from the executive editor: The 2023 STATUS List

Continuity nursing helped my family in our darkest PICU moments

H5N1 virus can be tracked in retail milk, scientists say

Peter Hotez and the public health issue of online harassment

Study finds gene variants tied to breast cancer risk in Black women

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Vertex cell therapy lets patients with type 1 diabetes stop insulin

hotspot

Vertex cell therapy lets patients with type 1 diabetes stop insulin

FDA poised to publish guidelines for clinical trial diversity

Making the case for fair compensation in clinical trials

H5N1 virus can be tracked in retail milk, scientists say

For longer

UpToDate has a racism problem: Dr. Stanley Goldfarb

Wikipedia

Wikipedia

explore

hotspot